The identifier MIRD-237 primarily appears in two distinct and unrelated contexts: as a specific media production code and as a reference number for technical reports in medical radiation dosimetry. MIRD-237 in Media Production
The MIRD-237: A New Era in Radioisotope Thermoelectric Generators
The MIRD-237: A Comprehensive Review of its History, Development, and Applications
The MIRD-237, also known as Lutetium-177 (Lu-177) or MIRD 237, is a radioactive isotope of the element Lutetium. It has a half-life of approximately 6.75 days and decays through beta emission to become stable Hafnium-177. The MIRD-237 has been widely used in nuclear medicine and radiation therapy for the treatment of various types of cancer, including neuroendocrine tumors, prostate cancer, and certain types of lymphoma.
Chemical and Radiochemical Characterization
If you're looking for detailed information on MIRD-237, I recommend checking the official publications of the SNMMI or other relevant scientific databases that catalog such reports. They may offer direct access to the document or more information on its content and relevance to current practices in nuclear medicine and dosimetry.